ProCE Banner Activity

A Year in Review: Experts Illuminate the Potential of ADCs Targeting HER2, HER3, and TROP-2 in NSCLC

Events

Share

Provided by

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc.

AstraZeneca

Daiichi Sankyo, Inc.